Boston Scientific diskutieren
Boston Scientific
WKN: 884113 / Symbol: BSX / Name: Boston Scient / Aktie / Ausrüstung & Versorgung / Large Cap /
71,50 €
0,00 %
Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at UBS Group AG from $74.00 to $90.00. They now have a "buy" rating on the stock.
Ratings data for BSX provided by MarketBeat
Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at Mizuho from $80.00 to $85.00. They now have a "buy" rating on the stock.
Ratings data for BSX provided by MarketBeat
Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at Royal Bank of Canada from $78.00 to $82.00. They now have an "outperform" rating on the stock.
Ratings data for BSX provided by MarketBeat
Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at Raymond James from $73.00 to $85.00. They now have a "strong-buy" rating on the stock.
Ratings data for BSX provided by MarketBeat
Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at JPMorgan Chase & Co. from $72.00 to $82.00. They now have an "overweight" rating on the stock.
Ratings data for BSX provided by MarketBeat
Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at Barclays PLC from $70.00 to $78.00. They now have an "overweight" rating on the stock.
Ratings data for BSX provided by MarketBeat
Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at Mizuho from $85.00 to $90.00. They now have a "buy" rating on the stock.
Ratings data for BSX provided by MarketBeat
Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at Citigroup Inc. from $85.00 to $87.00. They now have a "buy" rating on the stock.
Ratings data for BSX provided by MarketBeat
Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at Argus from $80.00 to $95.00. They now have a "buy" rating on the stock.
Ratings data for BSX provided by MarketBeat
Boston Scientific Co. (NYSE: BSX) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for BSX provided by MarketBeat
Boston Scientific Co. (NYSE: BSX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $82.00 price target on the stock.
Ratings data for BSX provided by MarketBeat
Neueste Beiträge
BullzEye in Apple Inc. diskutieren